Tri-weekly exercise sessions not enough to keep fit

Body Fitness
Sydney, Sept. 3 : A new report by consumer group Choice dismisses effectiveness of tri-weekly exercise sessions, stretching before training to warm muscles and reduce injury, and "no pain, no gain" mantra as mere misconceptions.

The group says that these are nothing more than common exercising myths propagated by eager fitness instructors or lax health groups, who have not got all the facts.

Stem cells can help heart patients 'grow their own' heart valves

London, Sept 3 : British surgeons have created a groundbreaking treatment that will help create heart tissue from stem cells from the patient's body.

The treatment will help cadiac patients 'grow their own' heart valves and have them transplanted by surgeons.

Study confirms that the more you work, the less you sleep

Sleep
London, Sept 3 : The time you spend working is the single most important factor that has an impact on your sleep, reveals a new study.

The study, by researchers at the University of Pennsylvania, was carried out on nearly 50,000 US participants.

The participants were questioned on three different occasions - in 2003, 2004 and 2005 - and asked how they spent their time between 4am the previous day and 4am that day.

Plaza Centers plans to build 50 commercial centres across India

British Forces Quit Basra Base

Basra Palace
The British forces have quitted Basra Palace, Saddam Hussein’s quondam southern residence that became popular British base after the success of the US-led invasion.

The move has indicated the British disengagement from the conflict, and has highlighted the growing and public discord between Washington and London over Iraq. However, the America feels that the move will severely undermine security.

Diabetes drug shows promise to save millions of lives

Diabetes DrugsLondon, Sept. 3 : A drug that lowers blood pressure among diabetics may provide a significant means to save tens of thousands of lives, say UK scientists.

A five-year study conducted by them has shown that using Coversyl Plus-a combination of medication like ACE inhibitor and diuretic drugs, which are currently offered only to patients with high blood pressure-reduces the risk of death from heart-related problems and kidney failure by 18 per cent.

Pages

News in Focus

Players Use MocPOGO to Spoof Pokémon GO Location Without Getting Banned

As Pokemon GO becomes ever more popular, players around the globe are seeking safer, smarter ways to explore rare Pokemon spawns and participate in global raids--without leaving home.

Sun Pharmaceutical Share Price Target at Rs 1,960: Motilal Oswal Research

Motilal Oswal Financial Services has reiterated its BUY recommendation for Sun Pharma, assigning a 12-month target price of Rs 1,960, with the stock currently trading at Rs 1,690.

Ambuja Cements Share Price Target at Rs 718: Prabhudas Lilladher

Prabhudas Lilladher has reiterated BUY Call for Ambuja Cements, anchoring its target price at a solid Rs 718 per share.

Bharti Airtel Share Price Target at Rs 2,259: Prabhudas Lilladher

Prabhudas Lilladher research has issued an Accumulate Call on telecom major Bharti Airtel, driven by an impressive Q2FY26 performance that surpassed expectations.

From Cash to Crypto: How Indians Are Banking Differently in the Digital Age

There’s a quiet revolution happening in India’s financial world, and it’s not just about new banking apps or UPI limits being raised. It’s about how people think about money altogether.

Mahindra & Mahindra Share Price Target at Rs 4,122: Motilal Oswal Research

Motilal Oswal, a leading research house, has reiterated a BUY call on Mahindra & Mahindra (M&M) with a target price of Rs 4,122, citing robust earnings, margin expansion, and strong growth